Le Lézard
Classified in: Science and technology
Subjects: Conference, Trade Show, Award

Talus Named ISO of the Year by the Electronic Transactions Association


Talus, a fast-growing technology-driven provider of payment processing solutions for small and mid-sized merchants, today announced it was recently honored with a Star Award as Independent Sales Organization of the Year by the Electronic Transactions Association. The award recognizes an ISO member company whose actions move the payments industry forward while exhibiting high ethical standards and successfully addressing industry challenges with demonstrated business results. ETA also recognized Talus as one of the industry's Top 10 Payments ISVs for its Talus Pay mobile app.

"Talus is grateful to be honored as ETA's 2024 ISO of the Year," said CEO Kim Fitzsimmons. "This prestigious award is testament to the efforts the Talus team makes day-in and day-out to drive value to both our merchant partners and resellers by delivering white-glove service," added Fitzsimmons. "We are pleased that ETA also recognized the Talus Pay mobile app as we build-out a robust integrated software offering as an end-to-end payments technology provider."

ETA's Star Awards & Visa Celebration was held April 17, 2024, at Allegiant Stadium in Las Vegas in conjunction with the Association's annual TRANSACT conference which took place at the nearby Mandalay Bay Resort & Casino.

Talus has been an active member of ETA. Fitzsimmons has served on the Association's board of directors for nearly a decade and was board president for two years. Talus team members have served on numerous ETA volunteer committees, including Compliance, ISV, Sales & Strategy, Risk, Fraud & Security, and have received ETA's Top Payments Sales Representative and Forty Under 40 industry game-changer awards.

About Talus

Talus is transforming the payments economy, enabling small and mid-size businesses to thrive. The company provides integrated technology-enabled payment solutions, personalized in-house support and trusted advice delivered with exceptional care and attention?start to finish. Serving more than 22,000 merchants in North America, Talus processes 65 million transactions with +$9 billion in annual charge volume via direct and independent sales agents, and a partner network of financial institutions, independent sales organizations, independent software vendors and value-added resellers. Named 2024 ISO of the Year by the Electronic Transactions Association, Talus is a portfolio company of Alvarez & Marsal Capital ("AMC") a leading private equity firm with over $5.8 billion in assets under management. For more information, please visit the Talus website.


These press releases may also interest you

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: